Nanobiotix S.A.
NASDAQ:NBTXBiotechnology
-$0.33 today
- Market cap
- $1.37B
- Beta
- 0.59
- P/E (TTM)
- -60.2
- EPS (TTM)
- -$0.51
Volume 0.04M
Average 0.08M
NBTX Property, Plant & Equipment (Net)
Physical long-term assets such as land, buildings, and machinery, net of accumulated depreciation.
Nanobiotix S.A.NASDAQ: NBTX
Property, Plant & Equipment (Net) · Q4 FY2025 · quarter ended Dec 2025
Property, plant & equipment (net) falls 17.6% from a year ago
Property, plant & equipment (net) stood at €4.57M at the end of Q4 FY2025, down 17.6% from a year earlier. Over 3 fiscal years it compounded at -13.8% a year.
Context
- Property, plant & equipment (net) amounted to 6.7% of total assets at the end of Q4 FY2025, down 1.5 pp from a year earlier.
- Property, plant & equipment (net) increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether property, plant & equipment (net) keeps falling in the next quarterly balance sheet after a -17.6% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Property, Plant & Equipment (Net) history
EUR · from the balance sheet
- Latest · FY2025
- 4.57M EUR
- Year-over-year change
- -17.6%
- 4-year CAGR
- -13.6%
| Period | Period end | Property, Plant & Equipment (Net) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 4.57M | -17.6% |
| FY2024 | 2024-12-31 | 5.54M | -9.3% |
| FY2023 | 2023-12-31 | 6.11M | -14.2% |
| FY2022 | 2022-12-31 | 7.12M | -13.0% |
| FY2021 | 2021-12-31 | 8.19M | — |
Property, Plant & Equipment (Net) vs competitors
How NBTX compares with its peers on the latest reported figures
- Peers report in different currencies, so property, plant & equipment (net) is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -17.6% is the 7th highest of 9, against a peer median of +10.3%.
- Property, plant & equipment (net) amounts to 6.7% of total assets for NBTX, versus a peer median of 2.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $142.66M USD | — | -8.0% | 23.4% | |
| Mar 2026 | $14.78M USD | +40.9% | +33.4% | 2.3% | |
| Mar 2026 | $9.1M USD | -53.5% | -29.3% | 6.8% | |
| Mar 2026 | $6.66M USD | -10.8% | +24.8% | 1.6% | |
| Mar 2026 | $4.7M USD | +12.1% | -23.7% | 2.4% | |
| Dec 2025 | €4.57M EUR | -17.6% | -13.8% | 6.7% | |
| Mar 2026 | $3.64M USD | +49.8% | — | 1.8% | |
| Mar 2026 | $3.36M USD | +8.5% | +893.3% | 3.5% | |
| Mar 2026 | $1.39M USD | -22.9% | +12.9% | 0.3% | |
| Mar 2026 | $370K USD | +208.3% | -54.6% | 0.1% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding NBTX) | — | +10.3% | +2.4% | 2.0% | |
Competitors are the stored peer set for NBTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 83.92M | 41.39M | 75.28M | 49.74M | 52.75M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 3.89M | 2.84M | 2.97M | 8.54M | 7.68M |
| Inventory | 0 | 2.98M | 200K | 0 | 0 |
| Other Current Assets | 3.04M | 2.17M | 6.33M | (1K) | 2K |
| Total Current Assets | 93.06M | 52.36M | 87.34M | 61.47M | 62.75M |
| Property, Plant & Equipment (Net) | 8.19M | 7.12M | 6.11M | 5.54M | 4.57M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 4K | 1K | 8K | 7K | 10K |
| Long-term Investments | 98K | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 421K | 291K | 443K | 406K | 434K |
| Total Non-current Assets | 8.71M | 7.41M | 6.56M | 5.95M | 5.01M |
| Total Assets | 101.77M | 59.77M | 93.9M | 67.42M | 67.76M |
| Account Payables | 5M | 4M | 6.7M | 4.48M | 6.58M |
| Short-term Debt | 7.08M | 3.6M | 3.82M | 3.66M | 3.1M |
| Tax Payables | 5.08M | 6.6M | 7.38M | 6.87M | 6.82M |
| Deferred Revenue | 16.77M | 16.57M | 18.23M | 18.16M | 36.22M |
| Other Current Liabilities | 5.39M | 7.41M | 760K | 8.27M | 430K |
| Total Current Liabilities | 36.85M | 37.94M | 49.87M | 58.94M | 57.51M |
| Long-term Debt | 32.42M | 44.04M | 41.66M | 43.01M | 89.12M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 318K | 270K | 325K | 28.21M | 3.73M |
| Total Non-current Liabilities | 38.13M | 48.88M | 45.87M | 74.19M | 94.74M |
| Total Liabilities | 74.98M | 86.81M | 95.74M | 133.12M | 152.24M |
| Common Stock | 1.05M | 1.05M | 1.41M | 1.42M | 1.45M |
| Retained Earnings | (47M) | (57.04M) | (39.7M) | (68.13M) | (23.96M) |
| Accumulated OCI | (182.82M) | (226.58M) | (276.07M) | (311.51M) | (376.15M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 26.79M | (27.05M) | (1.84M) | (65.7M) | (84.48M) |
| Total Debt | 46.02M | 53.17M | 50.57M | 50.9M | 95.32M |
| Net Debt | (37.9M) | 11.78M | (24.72M) | 1.17M | 42.57M |
Nanobiotix S.A.
NASDAQ:NBTX
Intrinsic Alpha fair value
Locked
Current Price
$26.90
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.